Research Nurse Blood Cancer

at  McKesson

IT’S MORE THAN A CAREER, IT’S A MISSION.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

• You will be enrolling patients onto clinical trials through recruitment, screening, enrollment, treatment, and follow-up of eligible participants according to protocol requirements.
• You will review the study design and inclusion/exclusion criteria with physician and patient.
• You will ensure the protection of study patients by verifying informed consent procedures and adhering to protocol requirements.
• You will use the protocol as the only tool to screen, treat, and follow patients.
• You will complete and document screening/eligibility accurately.
• You will complete and document the informed consent process accurately and has all parties sign/date as required, including HIPAA Authorization.
• You will accurately complete and submit on-study forms within two weeks of enrollment.
• You will ensure that patient documentation is completed at each clinic visit while in screening.
• You will ensure that all medications are approved prior to initiating treatment or when changing medication regimens, such as crossover studies.
• You will accurately calculate and document BSA, Creatinine Clearance, Urine Protein: Creatinine ratio, and any other calculations or conversions required per protocol.
• You will ensure that follow-up appointments, scans, or related procedures are scheduled correctly according to protocol requirements.
• You will document appropriately when patients are removed from protocol.
• You will ensure reconsent of patients at the next scheduled visit, following availability of updated ICF, and documents process appropriatel